{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:03:05Z","timestamp":1775142185073,"version":"3.50.1"},"reference-count":70,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>One potential association that is gaining increasing attention is the link between multiple sclerosis (MS) and migraine, which are suggested to frequently coexist in young patients. This is the first study to analyze the levels of multiple markers of oxidative stress in sociodemographically similar groups of patients with migraine, MS, and both MS and migraine. A single cross-sectional study was conducted at the Department of Neurology, Rzesz\u00f3w University. The study included 110 participants, comprising 26 healthy controls, 24 subjects with migraines, 30 with MS, and 30 with both MS and migraine. Oxidative stress markers were measured in patients\u2019 serum. Patients with MS and migraines had statistically elevated levels of 3-nitrotyrosine, Amadori products, 4-hydroxy-nonenal, and oxidative damage to amino acids. Moreover, we observed reduced levels of thiol groups and total antioxidant capacity in the serum of patients with MS and migraines compared to healthy controls. The co-occurrence of migraines in MS leads to greater oxidative stress than MS alone. The impact of chronic oxidative stress on both MS and migraines may exacerbate symptoms and deteriorate the quality of life.<\/jats:p>","DOI":"10.3390\/antiox14050511","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T10:17:16Z","timestamp":1745489836000},"page":"511","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated Oxidative Stress in Patients with Coexisting Multiple Sclerosis and Migraine: A Cross-Sectional Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-1316","authenticated-orcid":false,"given":"Iwona","family":"Ro\u015bciszewska-\u017bukowska","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Rzesz\u00f3w, Warzywna 1a, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Biesiadecki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rzesz\u00f3w, Warzywna 1a, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-6788","authenticated-orcid":false,"given":"Mateusz","family":"Mo\u0142o\u0144","sequence":"additional","affiliation":[{"name":"Faculty of Biology and Nature Protection, University of Rzesz\u00f3w, Zelwerowicza 4, 35-601 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Ro\u017cek","sequence":"additional","affiliation":[{"name":"Faculty of Biology and Nature Protection, University of Rzesz\u00f3w, Zelwerowicza 4, 35-601 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Bartosik-Psujek","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rzesz\u00f3w, Warzywna 1a, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-3553","authenticated-orcid":false,"given":"Sabina","family":"Galiniak","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rzesz\u00f3w, Warzywna 1a, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Eva, L., Ple\u0219, H., Covache-Busuioc, R.-A., Glavan, L.A., Bratu, B.-G., Bordeianu, A., Dumitrascu, D.-I., Corlatescu, A.D., and Ciurea, A.V. (2023). A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092489"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vitturi, B.K., Montecucco, A., Rahmani, A., Dini, G., and Durando, P. (2023). Occupational Risk Factors for Multiple Sclerosis: A Systematic Review with Meta-Analysis. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1285103"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1212\/NXI.0000000000000517","article-title":"Disease-Modifying Therapies Alter Gut Microbial Composition in MS","volume":"6","author":"Zhu","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(12)70309-5","article-title":"Epigenetic Mechanisms in Multiple Sclerosis: Implications for Pathogenesis and Treatment","volume":"12","author":"Huynh","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2011.12.012","article-title":"Exploring the Role of the Epigenome in Multiple Sclerosis: A Window onto Cell-Specific Transcriptional Potential","volume":"248","author":"Kaliszewska","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ro\u015bciszewska-\u017bukowska, I., Galiniak, S., and Bartosik-Psujek, H. (2023). Clinical Characteristics of Headache in Multiple Sclerosis Patients: A Cross-Sectional Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103518"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104152","DOI":"10.1016\/j.msard.2022.104152","article-title":"Multiple Sclerosis and Migraine: Links, Management and Implications","volume":"68","author":"Mrabet","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Adamczyk, B., Morawiec, N., Boczek, S., Da\u0144da, K., Herba, M., Spyra, A., Sowa, A., Szczygie\u0142, J., and Adamczyk-Sowa, M. (2024). Headache in Multiple Sclerosis: A Narrative Review. Med. Kaunas Lith., 60.","DOI":"10.3390\/medicina60040572"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"S\u00eerbu, C.A., Rotaru, A.R., Antochi, F.A., Plesa, A., Manole, A.M., and Roceanu, A.M. (2024). Headache and Other Pain Syndromes in Multiple Sclerosis: A Narrative Review. Life, 14.","DOI":"10.3390\/life14010087"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105602","DOI":"10.1016\/j.msard.2024.105602","article-title":"Prevalence of Primary Headaches in Multiple Sclerosis Patients","volume":"86","author":"Naseer","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Qian, Z., Li, Y., Guan, Z., Guo, P., Zheng, K., Du, Y., Yin, S., Chen, B., Wang, H., and Jiang, J. (2023). Global, Regional, and National Burden of Multiple Sclerosis from 1990 to 2019: Findings of Global Burden of Disease Study 2019. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1073278"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hollen, C., Neilson, L.E., Barajas, R.F., Greenhouse, I., and Spain, R.I. (2023). Oxidative Stress in Multiple Sclerosis\u2014Emerging Imaging Techniques. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.1025659"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7191080","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chaudhary, P., Janmeda, P., Docea, A.O., Yeskaliyeva, B., Abdull Razis, A.F., Modu, B., Calina, D., and Sharifi-Rad, J. (2023). Oxidative Stress, Free Radicals and Antioxidants: Potential Crosstalk in the Pathophysiology of Human Diseases. Front. Chem., 11.","DOI":"10.3389\/fchem.2023.1158198"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10194-016-0606-0","article-title":"Oxidative Stress and DNA Damage in Patients with Migraine","volume":"17","author":"Geyik","year":"2016","journal-title":"J. Headache Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0972-2327.56316","article-title":"Comparison of Oxidative Stress among Migraineurs, Tension-Type Headache Subjects, and a Control Group","volume":"12","author":"Gupta","year":"2009","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, Y., Yue, G., and Zhao, Y. (2023). Energy Metabolism Disturbance in Migraine: From a Mitochondrial Point of View. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1133528"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/ars.2012.4720","article-title":"Severe Life Stress and Oxidative Stress in the Brain: From Animal Models to Human Pathology","volume":"18","author":"Schiavone","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e27426","DOI":"10.1016\/j.heliyon.2024.e27426","article-title":"Association between Oxidative Balance Score and Self-Reported Severe Headache or Migraine Based on NHANES 1999 to 2004 Data: A Cross-Sectional Study","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"ref_20","first-page":"157","article-title":"The Effects of Disease-Modifying Therapies on Oxidative Stress in Patients With Relapsing-Remitting Multiple Sclerosis","volume":"45","author":"Topic","year":"2022","journal-title":"Clin. Neuropharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bizo\u0144, A., Chojdak-\u0141ukasiewicz, J., Ko\u0142tuniuk, A., Budrewicz, S., Pokryszko-Dragan, A., and Piwowar, A. (2022). Evaluation of Selected Oxidant\/Antioxidant Parameters in Patients with Relapsing-Remitting Multiple Sclerosis Undergoing Disease-Modifying Therapies. Antioxidants, 11.","DOI":"10.3390\/antiox11122416"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Delic, S., Miletic Drakulic, S., Stepovic, M., Milosavljevic, J., Kovacevic Dimitrijevic, M., Jovanovic, K., Marinkovic, I., Tepavcevic, M., Janicijevic, N., and Mitrovic, A. (2025). The Connection Between Oxidative Stress, Mitochondrial Dysfunction, Iron Metabolism and Microglia in Multiple Sclerosis: A Narrative Review. NeuroSci, 6.","DOI":"10.3390\/neurosci6010023"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gross, E.C., Putananickal, N., Orsini, A.-L., Vogt, D.R., Sandor, P.S., Schoenen, J., and Fischer, D. (2021). Mitochondrial Function and Oxidative Stress Markers in Higher-Frequency Episodic Migraine. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-84102-2"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_25","unstructured":"(2018). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd Edition. Cephalalgia, 38, 629\u2013808."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein Measurement with the Folin Phenol Reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue Sulfhydryl Groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(83)90078-5","article-title":"Fructosamine: A New Approach to the Estimation of Serum Glycosylprotein. An Index of Diabetic Control","volume":"127","author":"Johnson","year":"1983","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1365-2958.2005.04504.x","article-title":"Evidence for Non-Enzymatic Glycosylation of Escherichia Coli Chromosomal DNA","volume":"55","author":"Mironova","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The Ferric Reducing Ability of Plasma (FRAP) as a Measure of \u201cAntioxidant Power\u201d: The FRAP Assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0076-6879(84)05042-4","article-title":"Assay for Blood Plasma or Serum","volume":"105","author":"Yagi","year":"1984","journal-title":"Methods Enzymol."},{"key":"ref_33","first-page":"669","article-title":"Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA","volume":"35","author":"Keis","year":"1997","journal-title":"Eur. J. Clin. Chem. Clin. Biochem. J. Forum Eur. Clin. Chem. Soc."},{"key":"ref_34","first-page":"1968","article-title":"Advanced Glycated End-Products (AGE) during Haemodialysis Treatment: Discrepant Results with Different Methodologies Reflecting the Heterogeneity of AGE Compounds","volume":"14","author":"Henle","year":"1999","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.\u2014Eur. Ren. Assoc."},{"key":"ref_35","unstructured":"Diplock, A.T., Rice-Evans, C.A., and Symons, M.C.R. (1991). Techniques in Free Radical Research. Elsevier."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Arif, B., Arif, Z., Ahmad, J., Perveen, K., Bukhari, N.A., Ashraf, J.M., and Alam, K. (2022). Attenuation of Hyperglycemia and Amadori Products by Aminoguanidine in Alloxan-Diabetic Rabbits Occurs via Enhancement in Antioxidant Defenses and Control of Stress. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262233"},{"key":"ref_37","first-page":"1495","article-title":"Headache in Children and Dynamic Thiol\/Disulfide Balance Evaluation with a New Method","volume":"38","author":"Kurt","year":"2017","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13760-015-0427-y","article-title":"Oxidative Stress and Decreased Thiol Level in Patients with Migraine: Cross-Sectional Study","volume":"115","author":"Eren","year":"2015","journal-title":"Acta Neurol. Belg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1468-2982.2009.01964.x","article-title":"Increased Nitric Oxide Stress Is Associated with Migraine","volume":"30","author":"Gruber","year":"2010","journal-title":"Cephalalgia Int. J. Headache"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1620\/tjem.211.23","article-title":"Increased Nitrosative and Oxidative Stress in Platelets of Migraine Patients","volume":"211","author":"Yilmaz","year":"2007","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"880","DOI":"10.14336\/AD.2017.1121","article-title":"Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging","volume":"9","author":"Fournet","year":"2018","journal-title":"Aging Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12011-008-8193-9","article-title":"Oxidative Stress in Migraine with and without Aura","volume":"126","author":"Tuncel","year":"2008","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Togha, M., Razeghi Jahromi, S., Ghorbani, Z., Ghaemi, A., and Rafiee, P. (2019). An Investigation of Oxidant\/Antioxidant Balance in Patients with Migraine: A Case-Control Study. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1555-4"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Dini, E., Mazzucchi, S., De Luca, C., Cafalli, M., Chico, L., Lo Gerfo, A., Siciliano, G., Bonuccelli, U., Baldacci, F., and Gori, S. (2019). Plasma Levels of Oxidative Stress Markers, before and after BoNT\/A Treatment, in Chronic Migraine. Toxins, 11.","DOI":"10.3390\/toxins11100608"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Salahi, M., Parsa, S., Nourmohammadi, D., Razmkhah, Z., Salimi, O., Rahmani, M., Zivary, S., Askarzadeh, M., Tapak, M.A., and Vaezi, A. (2022). Immunologic Aspects of Migraine: A Review of Literature. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.944791"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Peggion, C., Cal\u00ec, T., and Brini, M. (2024). Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?. Antioxidants, 13.","DOI":"10.3390\/antiox13020240"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/head.12725","article-title":"Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis","volume":"56","author":"Borkum","year":"2016","journal-title":"Headache"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s12035-019-01856-7","article-title":"Antioxidant and Anti-Inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study","volume":"57","author":"Mezzaroba","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2014.09.024","article-title":"Plasmatic Oxidative Stress Biomarkers in Multiple Sclerosis: Relation with Clinical and Demographic Characteristics","volume":"48","author":"Pasquali","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuint.2013.02.025","article-title":"The Patients with Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis Show Different Levels of Advanced Protein Oxidation Products and Total Thiol Content in Plasma and CSF","volume":"62","author":"Ljubisavljevic","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/13510002.2017.1325571","article-title":"Markers of Oxidative\/Nitrative Damage of Plasma Proteins Correlated with EDSS and BDI Scores in Patients with Secondary Progressive Multiple Sclerosis","volume":"22","author":"Morel","year":"2017","journal-title":"Redox Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Arslan, B., Arslan, G.A., Tuncer, A., Karabudak, R., and Din\u00e7el, A.S. (2021). Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.716195"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s12035-016-9860-z","article-title":"Albumin and Protein Oxidation Are Predictors That Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis","volume":"54","author":"Oliveira","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s10072-020-04928-y","article-title":"Superoxide Dismutase (SOD), Advanced Oxidation Protein Products (AOPP), and Disease-Modifying Treatment Are Related to Better Relapse Recovery after Corticosteroid Treatment in Multiple Sclerosis","volume":"42","author":"Obradovic","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"F\u00f6rster, M., Nelke, C., R\u00e4uber, S., Lassmann, H., Ruck, T., Sormani, M.P., Signori, A., Hartung, H.-P., K\u00fcry, P., and Meuth, S.G. (2021). Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121899"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5114\/aoms.2020.95654","article-title":"Carboxymethyllysine and Carboxyethyllysine in Multiple Sclerosis Patients","volume":"20","author":"Kumaszka","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1352458510384123","article-title":"Plasma Pentosidine: A Potential Biomarker in the Management of Multiple Sclerosis","volume":"17","author":"Sternberg","year":"2011","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"ref_58","first-page":"167","article-title":"Advanced Glycoxidation End Products in Patients with Multiple Sclerosis","volume":"106","author":"Spacek","year":"2005","journal-title":"Prague Med. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.15584\/ejcem.2017.3.10","article-title":"Clinical Aspects of Protein Glycation","volume":"15","author":"Galiniak","year":"2018","journal-title":"Eur. J. Clin. Exp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"110702","DOI":"10.1016\/j.mehy.2021.110702","article-title":"Advanced Glycation End-Products as Potential Triggering Factors of Self-Reactivity against Myelin Antigens in Multiple Sclerosis","volume":"157","author":"Polykretis","year":"2021","journal-title":"Med. Hypotheses"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102941","DOI":"10.1016\/j.msard.2021.102941","article-title":"Serum Malondialdehyde as a Lipid Peroxidation Marker in Multiple Sclerosis Patients and Its Relation to Disease Characteristics","volume":"51","author":"Ghonimi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Podbielska, M., O\u2019Keeffe, J., and Pokryszko-Dragan, A. (2021). New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147319"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"708659","DOI":"10.1155\/2013\/708659","article-title":"Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000363515","article-title":"Oxidative Stress Induced by Lipid Peroxidation Is Related with Inflammation of Demyelination and Neurodegeneration in Multiple Sclerosis","volume":"72","author":"Wang","year":"2014","journal-title":"Eur. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","article-title":"Oligodendrocyte Death and Myelin Loss in the Cuprizone Model: An Updated Overview of the Intrinsic and Extrinsic Causes of Cuprizone Demyelination","volume":"17","author":"Zirngibl","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Adamczyk, B., Niedziela, N., and Adamczyk-Sowa, M. (2017). Novel Approaches of Oxidative Stress Mechanisms in the Multiple Sclerosis Pathophysiology and Therapy. Exon Publ., 155\u2013171.","DOI":"10.15586\/codon.multiplesclerosis.2017.ch10"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2016.02.010","article-title":"Role of Dimethyl Fumarate in Oxidative Stress of Multiple Sclerosis: A Review","volume":"1019","author":"Suneetha","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"106500","DOI":"10.1016\/j.clineuro.2021.106500","article-title":"Oxidative Stress Activity of Fingolimod in Multiple Sclerosis","volume":"202","author":"Yevgi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"101946","DOI":"10.1016\/j.msard.2020.101946","article-title":"Why Do Multiple Sclerosis and Migraine Coexist?","volume":"40","author":"Say","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11910-022-01195-6","article-title":"Migraine and Diet: Updates in Understanding","volume":"22","author":"Moskatel","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/5\/511\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:20:58Z","timestamp":1760030458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/5\/511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["antiox14050511"],"URL":"https:\/\/doi.org\/10.3390\/antiox14050511","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}